CLINICAL_TRIALS
trial_result
· 2022-05-10
Clinical Trial Update: Effects of Oral Sildenafil on Mortality in Adults With PAH [Phase 4]
Summary
Phase 4 trial evaluating the effects of oral sildenafil on mortality in adults with pulmonary arterial hypertension has been terminated; results were posted in …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Pulmonary Arterial Hypertension | Phase 4 | Status: TERMINATED | Results posted: 2022-05-10